Terms: = Leukemia AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Staging
13 results:
1. Long non-coding RNA small nucleolar RNA host gene 29 drives chronic myeloid leukemia progression via microRNA-483-3p/Casitas B-lineage Lymphoma axis-mediated activation of the phosphoinositide 3-kinase/Akt pathway.
Feng X; Yang L; Liu X; Liu M; Liu L; Liu J; Luo J
Med Oncol; 2024 Jan; 41(2):60. PubMed ID: 38252204
[TBL] [Abstract] [Full Text] [Related]
2. TNF-α-308A allele Carrier Induced to Development of Chronic Lymphocytic leukemia in Sudanese Population at Earlier Age.
Basabaeen AA; Abdelgader EA; Ahmed Babekir E; Abdelateif NM; Osman Abdelrahim S; Awadalkareem Omer AY; Altayeb OA; Fadul EA; Ibrahim IK
Asian Pac J Cancer Prev; 2022 Oct; 23(10):3449-3455. PubMed ID: 36308371
[TBL] [Abstract] [Full Text] [Related]
3. Interleukin-10-1082A>G (rs1800896) Single Nucleotide Polymorphism is Not a Risk Factor of Chronic Lymphocytic leukemia in Sudanese Population.
Basabaeen AA; Abdelgader EA; Ahmed EB; Abdelateif NM; Osman Abdelrahim S; Sharif OM; Altayeb OA; Fadul EA; Osman Ibrahim I
Asian Pac J Cancer Prev; 2022 Sep; 23(9):3229-3235. PubMed ID: 36172689
[TBL] [Abstract] [Full Text] [Related]
4. Evaluation of immunophenotypic markers and clinico-hematological profile in chronic lymphocytic leukemia: implications for prognosis.
Bagheri M; Vosoughi T; Hosseinzadeh M; Saki N
BMC Res Notes; 2020 Sep; 13(1):412. PubMed ID: 32883360
[TBL] [Abstract] [Full Text] [Related]
5. [Clinicopathological features of myeloid sarcoma and DLBCL in the breast: a comparative study].
Chen DB; Zhang H; Kong FZ; Jiang Q; Fang XZ; Shen DH; Kan X
Zhonghua Bing Li Xue Za Zhi; 2020 Mar; 49(3):250-255. PubMed ID: 32187897
[No Abstract] [Full Text] [Related]
6. TP53 Gene 72 Arg/Pro (rs1042522) Single Nucleotide Polymorphism Contribute to Increase the Risk of B-Chronic Lymphocytic leukemia in the Sudanese Population.
Mohammed Basabaeen AA; Abdelgader EA; Babekir EA; Abdelrahim SO; Eltayeb NH; Altayeb OA; Fadul EA; Sabo A; Ibrahim IK
Asian Pac J Cancer Prev; 2019 May; 20(5):1579-1585. PubMed ID: 31128065
[TBL] [Abstract] [Full Text] [Related]
7. The specificity of immunophenotypic alterations in blasts in nonacute myeloid disorders.
Harrington A; Olteanu H; Kroft S
Am J Clin Pathol; 2010 Nov; 134(5):749-61. PubMed ID: 20959658
[TBL] [Abstract] [Full Text] [Related]
8. [Current options and principles of pathomorphology-based tumour diagnostics].
Povýsil C
Vnitr Lek; 2010 Jul; 56(7):709-14. PubMed ID: 20842917
[TBL] [Abstract] [Full Text] [Related]
9. Leukocytic-vascular endothelial growth factor and integrin alphavbeta3 in acute myeloid leukemia: relation to clinical outcome.
Abou-Shamaa LA; Mahmoud GN
Egypt J Immunol; 2008; 15(2):81-91. PubMed ID: 20306691
[TBL] [Abstract] [Full Text] [Related]
10. [Activity of the National Oncology R&D Consortium in 2004].
Tímár J;
Magy Onkol; 2005; 49(1):3-7. PubMed ID: 15902326
[TBL] [Abstract] [Full Text] [Related]
11. The value of fluorescence in situ hybridization in the diagnosis and prognosis of chronic lymphocytic leukemia.
Glassman AB; Hayes KJ
Cancer Genet Cytogenet; 2005 Apr; 158(1):88-91. PubMed ID: 15771912
[TBL] [Abstract] [Full Text] [Related]
12. [A case of gastric GIST treated preoperatively by imatinib mesylate].
Hiramatsu Y; Konno H; Kamiya K; Baba M; Ohta M; Kondo K; Yamamoto M; Kikuchi H; Tanaka T; Sugimura H; Nakamura S
Gan To Kagaku Ryoho; 2004 Aug; 31(8):1219-23. PubMed ID: 15332547
[TBL] [Abstract] [Full Text] [Related]
13. Optimal number of reagents required to evaluate hematolymphoid neoplasias: results of an international consensus meeting.
Braylan RC; Orfao A; Borowitz MJ; Davis BH
Cytometry; 2001 Feb; 46(1):23-7. PubMed ID: 11241503
[TBL] [Abstract] [Full Text] [Related]
